EXEL Prakiraan wutah bathi resik saben saham kanggo taun ngarep exelixis.com

Logo korporat perusahaan Exelixis Inc. (EXEL)

Exelixis, Inc. (EXEL) generates a steady cash flow and high margins due to the strong demand for Cabometyx. The GURU.Markets platform features this chart, where the projected growth in the company's net profit currently stands at 14.60. Production capacities are functioning flawlessly, ensuring the manufacture of medications. However, long-term success depends on clinical trial outcomes, patent protection, and insurance reimbursement policies.

EXEL: Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep Exelixis Inc 04.07.2022 - 14.11.2026

Rincian metrik keuangan lan pasar exelixis.com (EXEL)

- rega saham lan konsensus proyeksi valuasi:
Rega saham Exelixis Corp|EXEL - Prakiraan konsensus analis
- data kapitalisasi pasar:
Nilai pasar Exelixis|EXEL - Nilai Dipunlarasaken Utang lan Kas
- rincian nilai buku perusahaan:
Nilai Buku saben Saham Exelixis|EXEL - Nilai Buku Bisnis|Rasio Kapitalisasi Pasar marang Nilai Buku exelixis.com|EXEL - Aset Perusahaan
- indikator total utang lan likuiditas perusahaan:
Rasio Total Utang marang Ekuitas Exelixis, Inc.|EXEL - Rasio silihan jangka dawa marang modal|Utang jangka cendhak marang modal Exelixis|EXEL - Utang kumulatif perusahaan|Utang-utang marang kapitalisasi buku Exelixis|EXEL - Tanggungan utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Exelixis|Indikator likuiditas cepet exelixis.com
- informasi bathi lan kelipatan valuasi:
EXEL - Bathi sawise mbayar pajeg|Proyeksi bathi mangsa ngarep Exelixis, Inc.|EXEL - Nilai perusahaan marang bathi resik|Pangali Forward P/E Exelixis, Inc.|EXEL - Rega marang bathi kanthi panyesuaian wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Exelixis|EXEL - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi resik saben saham (EPS TTM) Exelixis|EXEL - Bathi resik saben saham (EPS TTM)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan exelixis.com|EXEL - Dinamika bathi saben saham ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep Exelixis, Inc.
- data dodolan lan asil:
EXEL - Total pendapatan perusahaan|Prakiraan volume dodolan Exelixis Corp|EXEL - Rega marang dodolan|Multiplikator forward rega marang pendapatan Exelixis
Analisis fundamental perusahaan:Exelixis Corp, EXEL
Produk merek exelixis.com

The earnings growth forecast for the coming year reflects the expected earnings per share (EPS) dynamics, serving as an indicator of the issuer's future financial stability and market value. For Exelixis, Inc. (EXEL), this metric depends directly on the outcome of costly clinical trials and the protection of its patent monopoly. By analyzing this 12-month expected EPS growth chart, one can assess the market's level of optimism regarding new drugs. Sharp fluctuations in this metric signal high risks of a drawdown during a change in the regulatory cycle.

Perusahaan pesaing

GMAB (Genmab US) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep Nuvalent Therapeutics|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Kymera Therapeutics (KYMR)|IDYA (ideayabio.com) - Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi kanggo taun ngarep ELVN (Enliven Therapeutics, Inc.)|Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep ORIC Pharmaceuticals Inc|Relay Pharma - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Nurix Corp|TYRA (Tyra Biosciences, Inc.) - Prakiraan wutah bathi saben saham kanggo taun ngarep|VSTM: Proyeksi tambahing bathi saben saham ing taun ngarep|GLUE (Monte Rosa Therapeutics, Inc.) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Cullinan Oncology CGEM|Prakiraan wutah bathi kanggo taun ngarep IMRX|C4 Therapeutics Corp - Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep|Black Diamond - Prakiraan wutah bathi saben saham kanggo taun ngarep|Dinamika bathi saben saham sing diarepake ing taun ngarep RPTX|PMVP: Prakiraan wutah bathi saben saham kanggo taun ngarep|Karyopharm Therapeutics - Proyeksi tambahing bathi saben saham ing taun ngarep|PPCB: Prakiraan wutah bathi kanggo taun ngarep|Cyclacel - Dinamika bathi saben saham sing diarepake ing taun ngarep|AADI (Aadi Bioscience Inc) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Aileron ALRN|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Blueprint Medicines (BPMC)|GLYC (glycomimetics.com) - Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi kanggo taun ngarep SWTX (SpringWorks)